Skip to main content
. 2022 Aug 20;17:194. doi: 10.1186/s13019-022-01940-5

Fig. 1.

Fig. 1

Trial profile. Note: other serious disease (21 cases) were exclused included Severe terminal disease with life expectancy < 6 months, primary pulmonary hypertension, venous thromboembolic disease, and severe valvular heart disease, cardiomyopathy, pericarditis. Others (7 cases) were exclused as family members give up treatment